#goldman-sachs
Latest news and interesting information about goldman-sachs.
Goldman Sachs Upgrades Marriott Vacations Stock
Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.
Goldman Sachs Upgrades Travel + Leisure Stock to Buy
Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.
Goldman Sachs raises STOXX 600 target to 660
Goldman Sachs raises STOXX 600 12-month target to 660, citing strong earnings and AI optimism. European stocks show resilience despite Middle East risks.
Goldman Sachs Initiates HawkEye 360 with Buy Rating
Goldman Sachs initiates HawkEye 360 with a Buy rating and $42 price target. Company shows 74% revenue growth and 82% gross margins. Read more on Bond.az.
Goldman Sachs Initiates Octave at Neutral
Goldman Sachs initiates Octave Intelligence with Neutral rating and $17 target. Learn about the company's transition and growth drivers.
Goldman Sachs M&A volumes near 2021 record
Goldman Sachs M&A volumes are approaching a 2021 record, driven by corporate activity. President John Waldron cites strong backlogs.
Goldman Sachs: Inflation Pressures Intensify Across Asia-Pacific
Goldman Sachs reports rising inflation pressures across Asia-Pacific economies after the Iran war and Strait of Hormuz closure, with sharpest increases in lower-income nations.
Goldman Sachs lifts S&P 500 target to 8,000 on earnings
Goldman Sachs raises S&P 500 year-end target to 8,000 from 7,600, citing strong corporate earnings and AI-driven growth.
Goldman Sachs Initiates Hemab Buy
Goldman Sachs initiates Hemab Therapeutics with buy rating. Sutacimig and HMB-002 target rare bleeding disorders.
Goldman Sachs Backs Seaport Stock
Goldman Sachs initiates coverage on Seaport Therapeutics with an Early-Stage Biotech rating. Learn about the company's platform and financials.
Equities and rates: historic link - Goldman Sachs
Goldman Sachs analyzes the historic relationship between equities and interest rates. Insights on global bond market shifts and investment strategies.
Goldman Sachs: Shift to Semiconductors
Goldman Sachs highlights hedge fund and mutual fund shift to semiconductors from software amid AI disruption. Semiconductor index SOX surges.
Goldman Sachs SWOT: stock navigates strong backlog, expense pressures
Goldman Sachs SWOT analysis: stock navigates strong backlog amid expense pressures. Outlook for 2026.
TikTok Shop's Impact on European Retail
Goldman Sachs report on TikTok Shop's impact on European retail. Social commerce growth and fashion sector insights.
Goldman flags key FX market shift
Goldman Sachs reports a key shift in FX market dynamics, with a stronger dollar and Asian central bank interventions.
Goldman Sachs Reinstates Ageas with Neutral
Goldman Sachs reinstates Ageas with Neutral rating, price target EUR70.
Goldman Sachs to pay $500 million for 1MDB lawsuit
Goldman Sachs agrees to pay $500 million to settle shareholder lawsuit over 1MDB scandal.
Global oil reserves drop at record pace
Global oil reserves are dropping at a record pace. Analysis from Goldman Sachs, impact of Middle East war, and risk of energy crisis.
Goldman Sachs Downgrades Eiffage Stock
Goldman Sachs downgrades Eiffage to Neutral, cuts price target to €148. Cites Europe and France economic challenges.
Goldman Sachs Reiterates Alphabet Stock Rating
Goldman Sachs reiterates Alphabet stock rating with a $450 target. AI progress and new products highlighted.
Goldman Sachs Upgrades Brambles on Subcontractor Exit
Goldman Sachs upgrades Brambles to Neutral after subcontractor exit. Stock drops 17%, but Bond.az analysis suggests undervaluation with $32.76 Fair Value.
Goldman Sachs Raises Kinetik Price Target to $54
Goldman Sachs raises Kinetik price target to $54 from $48, citing marketing gains and positive outlook. Maintains Buy rating.
Goldman Sachs Starts Telefonica with Sell on Value
Goldman Sachs initiated Telefonica with a Sell rating and $13.90 target. Stock at $14.02. FCF yield concerns arise.
Goldman Sachs Initiates Yesway Coverage with Neutral
Goldman Sachs initiates coverage on Yesway with Neutral rating and $28 target. Read about Yesway's growth plans and financials on Bond.az.
Goldman Sachs Starts Nationwide Health at Buy
Goldman Sachs starts Nationwide Health Properties with Buy rating and $20 target. Stock at $14.86, potential 35% gain.
Goldman: S&P 500 momentum may signal weaker returns
Goldman Sachs warns that S&P 500 momentum rally may lead to weaker returns. Analysis of AI-driven market and historical parallels.
Chinese officials meet Citigroup, Goldman chiefs
Chinese officials met with Citigroup and Goldman Sachs chiefs to discuss cooperation and market opening.
Fitch Cuts Goldman Sachs BDC Outlook to Negative
Fitch Ratings downgraded Goldman Sachs BDC's outlook to negative due to credit deterioration and elevated risk profile. GSBD non-accruals rose to 4.7%.
Fitch Changes Goldman Sachs BDC Outlook to Negative
Fitch Ratings downgrades Goldman Sachs BDC outlook to negative, citing low asset coverage and credit deterioration.
Goldman Sachs cuts Regenxbio target to $10
Goldman Sachs cuts Regenxbio (NASDAQ:RGNX) price target to $10 from $12 on RGX-202 regulatory uncertainty. Stock down 41% to $6.25.
...